By blocking EGFR phosphorylation, restoring PTEN, and activating caspases, it effectively suppresses tumor growth and overcomes resistance, highlighting its potential as a supportive therapy in TKI refractory lung cancer [208]. The gene discussed is EGFR; the disease is lung cancer.